CANDEL THERAPEUTICS INC (CADL) Stock Balance Sheet
NASDAQ:CADL • US1374041093
Current stock price
4.81 USD
-0.18 (-3.61%)
At close:
4.81 USD
0 (0%)
After Hours:
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 102.65M | 35.41M | 70.06M | 82.64M | 35.05M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 1.15M | 1.38M | 1.89M | 2.30M | 93.00K | |||
| Total Current Assets | 103.80M | 36.80M | 71.94M | 84.94M | 35.15M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.73M | 4.02M | 5.48M | 3.84M | 2.79M | |||
| Other Non-Current Assets | 329.00K | 382.00K | 266.00K | 424.00K | 349.00K | |||
| Total Non-Current Assets | 3.06M | 4.40M | 5.75M | 4.26M | 3.14M | |||
| TOTAL ASSETS | 106.87M | 41.20M | 77.69M | 89.20M | 38.28M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 463.00K | |||
| Current Portion Of LT Debt. | 9.89M | 8.89M | N/A | N/A | N/A | |||
| Accrued Expenses | 5.29M | 4.87M | 5.19M | 3.44M | 3.14M | |||
| Accounts Payable | 237.00K | 422.00K | 380.00K | 1.59M | 921.00K | |||
| Other Current Liabilities | 22.11M | 0.00 | 48.00K | 334.00K | 187.00K | |||
| Total Current Liabilities | 37.53M | 14.18M | 5.62M | 5.36M | 4.71M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.60M | 12.38M | 20.85M | 560.00K | 483.00K | |||
| Other Non-Current Liabilities | 407.00K | 1.89M | 3.51M | 19.15M | 7.59M | |||
| Total Non-Current Liabilities | 3.01M | 14.27M | 24.36M | 19.71M | 8.07M | |||
| TOTAL LIABILITIES | 40.54M | 28.46M | 29.98M | 25.07M | 12.78M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -192.21M | -137.03M | -99.09M | -80.30M | -44.17M | |||
| Additional Paid In Capital | 258.51M | 149.93M | 146.96M | 144.15M | 20.32M | |||
| Common Shares | 469.00K | 290.00K | 290.00K | 286.00K | 49.35M | |||
| Treasury Stock | -448.00K | -448.00K | -448.00K | N/A | N/A | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Shares Outstanding | 46.81M | 29.09M | 28.92M | 28.69M | 27.80M | |||
| Tangible Book Value per Share | 1.42 | 0.44 | 1.65 | 2.24 | -0.85 | |||
| Total Shareholders' Equity | 66.33M | 12.74M | 47.71M | 64.14M | 25.50M | |||
| TOTAL LIABILITIES AND EQUITY | 106.87M | 41.20M | 77.69M | 89.20M | 38.28M | |||
| Statistics | ||||||||
| Debt/Equity | 0.04 | 0.97 | 0.44 | 0.01 | 0.04 | |||
| Current Ratio | 2.77 | 2.59 | 12.81 | 15.84 | 7.46 | |||
| Return On Assets (ROA) | -51.63% | -92.08% | -24.19% | -40.50% | -46.18% | |||
| Return On Equity (ROE) | -83.19% | -297.68% | -39.39% | -56.32% | -69.34% | |||
All data in USD , ROIC based on taxRate of 0.21